ASX-listed Volpara Health climbs on contract with U.S.-based lung imaging firm

Volpara Health Technologies

08/09/2021 03:39

** ASX-listed shares of Volpara Health Technologies  VHT.AX 
rise as much as 1.2% to A$1.24
    ** The New Zealand-based cancer screening software maker
signs collaboration agreement with U.S.-based lung imaging
company Riverain Technologies  urn:newsml:reuters.com:*:nFWN2Q919P
    ** Says deal to drive cos expansion into U.S. lung cancer
screening market 
    ** Stock down nearly 15% YTD, as of last close    


 (Reporting by Riya Sharma in Bengaluru)
 ((Riya.Sharma@thomsonreuters.com;))